Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 20,689 results that match your search.20,689 results
  • A federal judge has ruled that Mylan Laboratories must be allowed to sell its generic copy of Bristol-Myers Squibb's highly profitable drug BuSpar.
  • The past year has seen a greater degree of maturity in the processing of trade mark disputes and predictability in foreseeing their outcome. Jeremy Phillips reviews 10 decisions from across Europe which symbolize the trend
  • A long-awaited and far-reaching new Civil Procedure Act came into force in Spain on January 8 2001, which will have a profound effect on all civil proceedings, including IP actions. Gonzalo Ulloa and Ralph Smith reveal the main changes
  • In the recent Festo decision, the Federal Circuit unveiled a new approach to analyzing the doctrine of equivalents and the companion doctrine of prosecution history estoppel. In light of this new approach, Allen R Jensen and Stacy D Lewis provide some guidelines for patentees
  • European electrical goods companies have teamed up with Chinese government inspectors to raid the factories of Chinese counterfeiters who are costing the industry millions of euros a year. The raids in Guangdong province in south China targeted factories producing counterfeit goods such as kettles, plugs, sockets and cookware being made to European companies' designs.
  • Conducting opposition proceedings at OHIM is full of pitfalls for the uninitiated. Tasneem Haq provides 10 rules to help trade mark owners achieve success
  • Business methods should remain unpatentable. That was the clear message coming from the UK last month. In a statement issued on March 13, the government stood firm in its position not to allow the patentability of business methods and to allow no change in the guidelines for patenting software. The government's stance is likely to bring the UK into direct conflict with the European Patent Office, the United States and the UK software industry, which believes it is losing out to its American colleagues.
  • A recent EPO decision has challenged the conventional exclusion on double patenting. Neil Thomson asks where the decision leaves EPO practice, and what impact it will have on proceedings in the UK
  • Due to growing importance of modern achievements of biotechnology in industry, agriculture and medicine, an adequate legal protection of IP rights in this field is one of the most vital issues world-wide (including in Russia) that needs to be solved for the benefit of public.
  • BRAZIL: From March 6, the Brazilian agency responsible for the registration of domain names (FAPESP) will allow registration by foreign companies. Before that date, registration could only be made by local companies.